1. Home
  2. BTO vs CATX Comparison

BTO vs CATX Comparison

Compare BTO & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Hancock Financial Opportunities Fund

BTO

John Hancock Financial Opportunities Fund

HOLD

Current Price

$35.66

Market Cap

666.0M

Sector

Finance

ML Signal

HOLD

Logo Perspective Therapeutics Inc.

CATX

Perspective Therapeutics Inc.

HOLD

Current Price

$4.41

Market Cap

569.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTO
CATX
Founded
N/A
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
666.0M
569.6M
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
BTO
CATX
Price
$35.66
$4.41
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$12.11
AVG Volume (30 Days)
53.0K
1.3M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$12.71
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.73
$1.60
52 Week High
$39.85
$6.16

Technical Indicators

Market Signals
Indicator
BTO
CATX
Relative Strength Index (RSI) 55.31 47.02
Support Level $35.10 $3.24
Resistance Level $36.75 $4.64
Average True Range (ATR) 0.86 0.36
MACD 0.33 -0.06
Stochastic Oscillator 89.19 38.10

Price Performance

Historical Comparison
BTO
CATX

About BTO John Hancock Financial Opportunities Fund

John Hancock Financial Opportunities Fund is a United States-based closed-end, diversified management investment company. Its investment objective is to provide a high level of total return consisting of long-term capital appreciation and current income. Under normal circumstances, the fund will invest at least 80% of its net assets in equity securities of U.S. and foreign financial services companies of any size. These companies may include, but are not limited to, banks, thrifts, finance and financial technology companies, brokerage and advisory firms, real estate-related firms, insurance companies, and financial holding companies.

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Share on Social Networks: